Media Search:



Nintendo 3DS XL Special Pikachu Edition Unboxing! – Video


Nintendo 3DS XL Special Pikachu Edition Unboxing!
I #39;ve never made a video like this, so I thought why not? I #39;m unboxing an official Pikachu Edition 3DS XL in this video! Be sure to leave a like if you liked ...

By: PokeCinema

Continued here:
Nintendo 3DS XL Special Pikachu Edition Unboxing! - Video

Ek Thi Daayan – Official Theatrical Trailer – Video


Ek Thi Daayan - Official Theatrical Trailer
#39;Main aa rahi hoon ... #39; Presenting the 2nd official theatrical trailer of #39;Ek Thi Daayan #39; starring Emraan Hashmi, Kalki Koechlin, Konkona Sen Sharma and Huma...

By: BalajiMotionPictures

Excerpt from:
Ek Thi Daayan - Official Theatrical Trailer - Video

KXEN Helps Skyrock.com Monetize Their Social Networking Community

SAN FRANCISCO--(BUSINESS WIRE)--

KXEN, the leading provider of predictive analytics for business users, today announced that Skyrock.com, one of the leading social sites in Europe, has successfully deployed KXENs InfiniteInsight Recommendation to improve stickiness and social engagement for its more than 18 million monthly visitors.

Were ecstatic with the results weve achieved thanks to KXEN, said Rmi Kirche, Marketing Director at Skyrock.com. KXENs InfiniteInsight Recommendation is giving us the ability to offer our members new services which have boosted engagement and overall site stickiness. Best of all, results with KXEN have been consistent over the past year, giving a real competitive advantage to our company.

Skyrock.com is one of the fastest growing social network sites in the world, offering its members a free, personal web space to create blogs, add a profile, and exchange messages with other registered members. To assist in monetizing the sites rapid growth, Skyrock.com made a strategic decision to improve their members overall experience which would increase site stickiness and provide more valuable advertising impressions.

To achieve this objective, Skyrock.com standardized on KXENs InfiniteInsight Recommendation, which, unlike traditional recommendation engines, analyzes massive amounts of Big Data to provide personalized recommendations, such as products, friends, content (like blog posts) and targeted ads, to each unique visitor. Big Data is valuable to companies like Skyrock.com, because it unlocks new sources of information that organizations could only dream of 5 years ago and can greatly increase prediction accuracy.

Skyrock.com uses InfiniteInsight Recommendation to analyze the volumes of Big Data collected on their website, including:

KXEN is committed to helping e-Businesses like Skyrock.com gain unparalleled insight about their members, said John Ball, CEO of KXEN. We believe that personalized recommendations are critical for todays e-Business to drive monetization of their websites.

Friend Recommendation

As a social site where content is viewed and shared between members, Skyrock.com uses InfiniteInsight Recommendation to offer a list of 20 relevant friend recommendations each morning to its members. Using this strategy, Skyrock.com has doubled the number of friend requests and their corresponding rate of acceptance. On average, Skyrock.com sees more than 600,000 new friend links each day.

Member Insight and Personalization

Read this article:
KXEN Helps Skyrock.com Monetize Their Social Networking Community

Experimental Drug May Work Against Hepatitis C

By Maureen Salamon HealthDay Reporter

WEDNESDAY, March 27 (HealthDay News) -- An experimental therapy for hepatitis C -- a "silent killer" linked to liver cancer and cirrhosis -- has shown promise in tamping down virus levels in early trials.

Experts caution, however, that it's too soon to know if the injectable drug will someday gain a standing among emerging oral medications against the disease.

New research suggests that the drug, miravirsen, could potentially be part of a drug "cocktail" that manages the hepatitis C virus in much the same way as similar combinations have transformed HIV/AIDS from a death sentence into a chronic, manageable condition.

Miravirsen suppresses molecules the hepatitis C virus needs to reproduce. The drug decreased viral loads by about 500-fold at the highest doses used in a small, phase 2 study by an international group of researchers. Drug resistance, a common problem with other hepatitis C medications, did not develop among patients taking miravirsen.

A phase 2 trial evaluates a drug's effectiveness while continuing to assess its safety.

"This is the first real clinical study of this approach and the results are encouraging," said Dr. Judy Lieberman, chairwoman of cellular and molecular medicine at Boston Children's Hospital. "What's exciting to me is that there doesn't seem to be any drug resistance developing. If there's a way to develop a drug cocktail that doesn't require a half a year of treatment ... that would be really exciting, but it's too early to tell."

Lieberman was not involved in the research but co-wrote an editorial accompanying the new study in the March 27 issue of the New England Journal of Medicine.

Hepatitis C is one form of liver disease and affects about 170 million people worldwide, according to study background information. It's transmitted by shared needles or, less frequently, through sex. Often symptomless, the infection is a major cause of liver cancer and cirrhosis, or scarring of the liver.

Led by Dr. Harry Janssen, a professor of medicine at the University of Toronto and Erasmus University Rotterdam in the Netherlands, researchers split 36 patients with hepatitis C into four groups. Nine patients in each of the first three groups received a dose of either 3 milligrams (mg), 5 mg or 7 mg of miravirsen per kilogram of body weight for 29 days, while the last nine patients received a placebo. All were followed for 18 weeks.

Go here to read the rest:
Experimental Drug May Work Against Hepatitis C

Software Superheros: Comic-Reading Apps for Tablets

Few things are so well-suited to mobile devices lush color and displays as comics, and forward-looking publishers are fast ushering out the age of Mylar polybags.

While virtually every comic publisher has a standalone app, ComiXologys overarching reader has become the dominant force in the field. With dozens of publishers and same-day releases, its an apt competitor for your local shop; with navigation that lets you effortlessly zoom in and pore over one panel at a time, its enough to go digital and never look back.

WIRED Search by creator to dive down the rabbit hole.

TIRED Notable publisher omission Dark Horse means no Mind MGMT, B.P.R.D., etc.

Free iOS | Free Android | Comics By ComiXology

Most manga readers scrape scanlation sites, which offer free Japanese-only works that fans have translated to English. But that presents a murky copyright situation. Manga powerhouse VIZ rises above the fray with its huge library of translated titles, unflopped (reading right-to-left, as in the Japanese originals).

WIRED Same-day-as-print, as well as some digital previews up to three months before publication. Huge archives include full runs of classics.

TIRED Lack of auto-resume forces you to set a bookmark before you close the appor lose your place.

See the article here:
Software Superheros: Comic-Reading Apps for Tablets